Market Insights Health Hospitals Inpatient Care

Midwifery - G20

The Midwifery market is anticipated to witness a significant rise in revenue, reaching a staggering US$98.37bn by 2024.
This projection takes into account the expected annual growth rate (CAGR 2024-2029) of 3.55%, which would ultimately contribute to a market volume of US$117.10bn by 2029.
When comparing the revenue generated globally in the Midwifery market, it is noteworthy that in the United States is expected to lead the way with an estimated revenue of US$34,040.00m in 2024.
This highlights in the United States' prominent position within the G20 countries in terms of revenue generation in the Midwifery market.
In the G20 country of Germany, there is a growing trend towards integrating midwifery services into hospitals for a more holistic approach to maternal care.

Key regions: France, United States, Canada, United Kingdom, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.